We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Label-Free Protein Assay System Certified Compatible with CCD Spectrometer Microplate Readers

By LabMedica International staff writers
Posted on 08 Aug 2012
Several instruments manufactured by one of Europe's leading producers of microplate spectrophotometers have been certified as to being completely compatible with a novel, label-free protein assay system.

SPECTROstar Nano, SPECTROstar Omega, FLUOstar Omega, POLARstar Omega, and PHERAstar FS are microplate readers equipped with CCD (charge-coupled device) spectrometers. More...
These instruments, made by the dedicated manufacturer of microplate readers BMG Labtech (Ortenberg,Germany) have been certified as being fully compatible with PharmaDiagnostics' (Zellik, Belgium) SoPRano assay system.

The SoPRano assay is based on an adaptation of surface plasmon resonance (SPR) technology known as localized surface plasmon resonance (LSPR). In this system, gold nano rods (GNR) in solution are coated with the protein of interest. When the target protein molecules attached to the surface of the GNR’s interact with a ligand, a highly reproducible and dose dependent absorbance change occurs, which manifests as a redshift in the maximum absorbance wavelength. This is measured on a standard absorbance plate reader in either 96- or 384-well format.

The SoPRano assay system does not require specialized SPR detection equipment. Instead, a standard liquid handler and UV-Vis plate reader (scanning) capable of signal measurement up to 1000 nm are all that are needed.

This technology is broadly enabling and has been adapted for a variety of applications in basic research, pharmaceutical discovery, and quality control. Current applications include real-time kinetics, antibody-antigen interactions, epitope mapping; protein-protein interaction assays, and small molecule protein-protein inhibition assays.

Dr. E. J. Dell, international marketing director at BMG Labtech, said, “Since the whole absorbance spectrum redshifts when molecules bind to the SoPRano GNR surface, a whole spectrum needs to be measured. In less than one second per well and at a resolution of one nanometer, our CCD spectrometer microplate readers can instantly capture an entire absorbance spectrum (220-1,000 nm). Other microplate readers have to ‘build’ the spectrum, this can take tens of seconds (or even minutes) and it is usually at a lower resolution. This makes BMG Labtech’s CCD spectrometer microplate readers perfect for the SoPRano label-free assay.”

“The BMG Labtech spectrometer technology and dedicated SoPRano software enhance data quality and ease of use for SoPRano users. The combination of the BMG Labtech readers and SoPRano technology now deliver label-free, high quality protein-protein interactions analysis at a cost level an order of magnitude lower than specialist SPR systems, making this valuable technique available to any life science lab”, said Julian Abery, vice president for business development at PharmaDiagnostics.

Related Links:
BMG Labtech



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Drug Testing Assays
Atellica DT 250 Analyzer
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.